We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRVO icon
76
CervoMed
CRVO
$25.6M
$17.1M 0.23%
+734,363
New +$9.8M
SPB icon
77
Spectrum Brands
SPB
$2.03B
$17.1M 0.23%
+191,568
New +$15.6M
KDP icon
78
Keurig Dr Pepper
KDP
$41.3B
$15.9M 0.21%
+519,139
New +$16M
ULTA icon
79
Ulta Beauty
ULTA
$23.2B
$14.9M 0.2%
28,503
+14,803
+108% +$7.65M
UBER icon
80
Uber
UBER
$143B
$14.9M 0.2%
193,296
+29,296
+18% +$2.1M
CHDN icon
81
Churchill Downs
CHDN
$6.06B
$14.8M 0.2%
119,304
+79,304
+198% +$9.58M
PLNT icon
82
Planet Fitness
PLNT
$4.05B
$14.7M 0.19%
234,271
+200,810
+600% +$13.4M
BABA icon
83
Alibaba
BABA
$304B
$14.5M 0.19%
+200,000
New +$14.7M
DDOG icon
84
Datadog
DDOG
$81.6B
$13.6M 0.18%
110,121
+8,474
+8% +$1.07M
SN icon
85
SharkNinja
SN
$25.5B
$13.3M 0.18%
213,696
-341,316
-61% -$18.1M
EL icon
86
Estee Lauder
EL
$30.9B
$13.3M 0.18%
+86,073
New +$12.2M
CRSP icon
87
CRISPR Therapeutics
CRSP
$4.99B
$13.1M 0.17%
192,000
+24,000
+14% +$1.72M
EAT icon
88
Brinker International
EAT
$9.75B
$12.9M 0.17%
+260,000
New +$11.5M
ERAS icon
89
Erasca
ERAS
$6.34B
$12.7M 0.17%
6,172,000
-1,924,000
-24% -$3.85M
TGT icon
90
Target
TGT
$66.8B
$12.7M 0.17%
71,663
+67,266
+1,530% +$10.2M
PFGC icon
91
Performance Food Group
PFGC
$18B
$11.5M 0.15%
154,390
+37,774
+32% +$2.78M
PARA
92
DELISTED
Paramount Global Class B
PARA
$11.4M 0.15%
967,308
-443,992
-31% -$5.58M
SGMO
93
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$11.4M 0.15%
+16,958,477
New +$12.3M
WDAY icon
94
Workday
WDAY
$42B
$11.3M 0.15%
41,312
+3,194
+8% +$909K
NVDA icon
95
NVIDIA
NVDA
$5.3T
$11.3M 0.15%
124,530
-75,240
-38% -$5.45M
S icon
96
SentinelOne
S
$7.12B
$10.7M 0.14%
460,125
+88,125
+24% +$2.3M
NARI
97
DELISTED
Inari Medical, Inc. Common Stock
NARI
$10.7M 0.14%
222,751
+176,429
+381% +$9.42M
IMCR icon
98
Immunocore
IMCR
$1.75B
$10.7M 0.14%
164,000
-148,000
-47% -$10.2M
DNMR
99
DELISTED
Danimer Scientific, Inc.
DNMR
$10.3M 0.14%
+235,250
New +$9.74M
ORLY icon
100
O'Reilly Automotive
ORLY
$76.2B
$10.2M 0.13%
135,150
+60,150
+80% +$4.21M

Similar funds

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.